HK40062425A - 适用於皮下施用的fcrn抑制剂的药物制剂 - Google Patents

适用於皮下施用的fcrn抑制剂的药物制剂 Download PDF

Info

Publication number
HK40062425A
HK40062425A HK62022052031.1A HK62022052031A HK40062425A HK 40062425 A HK40062425 A HK 40062425A HK 62022052031 A HK62022052031 A HK 62022052031A HK 40062425 A HK40062425 A HK 40062425A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical formulations
subcutaneous administration
inhibitors suitable
fcrn inhibitors
fcrn
Prior art date
Application number
HK62022052031.1A
Other languages
English (en)
Inventor
Filip BORGIONS
Stephanie Lemoult
Kris Meerschaert
Original Assignee
Argenx Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenx Bvba filed Critical Argenx Bvba
Publication of HK40062425A publication Critical patent/HK40062425A/zh

Links

HK62022052031.1A 2019-06-07 2020-06-05 适用於皮下施用的fcrn抑制剂的药物制剂 HK40062425A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/858,806 2019-06-07

Publications (1)

Publication Number Publication Date
HK40062425A true HK40062425A (zh) 2022-06-10

Family

ID=

Similar Documents

Publication Publication Date Title
IL288550A (en) Pharmaceutical compositions for fcrn inhibitors for subcutaneous administration
IL275639A (en) Formulation for RNA administration
EP3881827B8 (en) Formulation for administration of rna
AU2018297348A1 (en) Compositions for parenteral administration of therapeutic agents
EP3773730A4 (en) Drug delivery formulations
WO2019240699A3 (en) Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion
EP4027973B8 (en) Drug delivery formulations
EP3952924A4 (en) COMPOSITIONS AND METHODS OF ADMINISTRATION OF THERAPEUTIC PRODUCTS
EP4004017A4 (en) PLATE-ENABLED DELIVERY OF THERAPEUTIC COMPOUNDS
EP4114396A4 (en) METHODS OF ADMINISTRATION OF ELAGOLIX
EP4085911A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION FOR THE TREATMENT OF LIVER CANCER
SG11202104499RA (en) Pharmaceutical formulations for subcutaneous administration
HK40062425A (zh) 适用於皮下施用的fcrn抑制剂的药物制剂
EP4326265A4 (en) PHARMACEUTICAL FORMULATIONS OF HYDRONIDONE FOR DISEASES
EP3515438A4 (en) ACTIVE SUBSTANCE RELEASE SYSTEM FOR RELEASING INTEGRAL INHIBITORS
EP3982937A4 (en) PHARMACEUTICAL FORMULATIONS WITH GABOXADOL FOR THERAPEUTIC TREATMENT
EP4048678A4 (en) COMPOUNDS AND COMPOSITIONS FOR TREATING PARASITIC DISEASES
HK40041225A (zh) 用於施用rna的制剂
HK40075060A (zh) 替诺福韦艾拉芬的药物制剂
HK40082107A (zh) 用於皮下施用的抗cd38抗體的配製品
HK40073247A (zh) 达鲁酰胺的药物组合物
HK40051042A (zh) 用於药物递送的组合物及其使用方法
HK40052480A (zh) 奥德昔巴特的药物制剂
HK40042140A (zh) 皮肤病用药物制剂
HK40078214A (zh) 药物化合物和使用方法